O’Connor, O. “Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Heavily Pretreated Patients With Hematological Malignancies”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 1, no. 8, June 2009, doi:10.4081/hmr.v1i8.297.